Physician profile
John H Lee
NPI 1114910239
$6,388.59
in general payments reported to CMS, 2019-2025
21 companies · $2,257 in 2025
The $2,257 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.96 · 2022: $109 · 2023: $3,864 · 2024: $114 · 2025: $2,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,800 · Travel and Lodging: $1,868 · Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,800.00 |
| Travel and Lodging | $1,868.31 |
| Food and Beverage | $566.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $3,800.00 | 2023 | |
| Integra Lifesciences Corporation | $1,921.37 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Lilly USA, LLC | $124.78 | 2025 | Mounjaro, Zepbound |
| E.R. Squibb & Sons, L.L.C. | $108.44 | 2024-2025 | Eliquis, Camzyos |
| Vertex Pharmaceuticals Incorporated | $49.87 | 2025 | |
| Exact Sciences Corporation | $47.54 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Tactile Systems Technology INC | $40.55 | 2022 | |
| Medtronic, INC. | $33.52 | 2021 | |
| Glaxosmithkline, LLC. | $31.04 | 2023-2025 | Nucala |
| Boston Scientific Corporation | $30.86 | 2024 | Watchman Flx |
| Ethicon INC. | $25.76 | 2022 | |
| Pfizer INC. | $23.42 | 2022 | |
| Merck Sharp & Dohme LLC | $20.06 | 2025 | Gardasil 9, Enflonsia, Capvaxive |
| Daiichi Sankyo INC. | $19.80 | 2024 | Injectafer |
| Kls-Martin L.P. | $19.35 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18.22 | 2025 | Ozempic, Rybelsus |
| Abbvie INC. | $18.02 | 2025 | |
| Karl Storz Endoscopy-America | $17.95 | 2023 | Tele Pack |
| Actelion Pharmaceuticals US, INC. | $13.63 | 2025 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $12.97 | 2023 | Xarelto |
| Deciphera Pharmaceuticals INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.